Comparison of the outcomes of patients who underwent deceased-donor or living-donor liver transplantation after successful downstaging therapy

European Journal of Gastroenterology and Hepatology

Volumn 25, Issue 11, 2013, Pages 1340-1346

  Lei, Jianyong ^a   Yan, Lunan ^a   Wang, Wentao ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

downstage; hepatocellular carcinoma; liver; therapy; transplant

Indexed keywords

ADEFOVIR; ENTECAVIR; LAMIVUDINE; SORAFENIB;

ABDOMINAL ABSCESS; ADULT; ARTICLE; BILE LEAKAGE; CANCER SURVIVAL; CARDIOPULMONARY ARREST; CHEMOEMBOLIZATION; CHOLESTASIS; COMPARATIVE STUDY; DECEASED DONOR; FEMALE; FIBRINOLYTIC THERAPY; GRAFT VERSUS HOST REACTION; HEPATIC ARTERY THROMBOSIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; KIDNEY FAILURE; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER RESECTION; LIVER TRANSPLANTATION; LIVING DONOR; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORGAN DONOR; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PLEURA EFFUSION; PORTAL VEIN THROMBOSIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENCE FREE SURVIVAL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SURGICAL INFECTION;

ADULT; CARCINOMA, HEPATOCELLULAR; COMBINED MODALITY THERAPY; FEMALE; HEPATITIS B; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; NEOPLASM STAGING; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84885318489     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283622743     Document Type: Article

References (49)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2003. CA Cancer J Clin 2005; 55:74-108.
2. EI- Serag HB. Hepatocelluar carcinoma: an epidemiologic view. Clin Gastroenterol 2002; 35:S72-S78.
3. Willatt JM, Francis IR, Novelli PM, Vellody R, Pandya A, Krishnamurthy VN. Interventional therapies for hepatocellular carcinoma. Cancer Imaging 2012; 12:79-88.
4. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 224:693-699.
5. Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSD criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 2002; 8:765-774.
6. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 6:1394-1403.
7. EI-Serag HB, Marrero JA, Rudolph L, Reddy KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 2008; 134:1752-1763.
8. Yang T, Lu JH, Lin C, Shi S, Chen TH, Zhao RH, et al. Concomitant lung metastasis in patients with advanced hepatocellular carcinoma. World J Gastroenterol 2012; 18:2533-2539.
9. Klintmalm GB. Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg 1998; 228:479-490.
10. Shirabe K, Taketomi A, Morrita K, Soejima Y, Uchyama H, Kayashima H, et al. Comparative evaluation of expanded criteria for patients with hepatocellular carcinoma beyond the Milan criteria undergoing living-related donor liver transplantation. Clin Transplant 2011; 25:E491-E498.
11. Majno PE, Adam R, Bismuth H, Castaing D, Ariche A, Krissat J, et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997; 226:688-701.
12. Yao FY, Kerlan RK Jr, Hirose R, Davern TJ III, Bass NM, Feng S, et al. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology 2008; 48:819-827.
13. Ravaioli M, Grazi GL, Piscaglia F, Trevisani F, Cescon M, Erolani G, et al. Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria. Am J Transplant 2008; 8:2547-2557.
14. De Luna W, Sze DY, Ahmed A, Ha BY, Ayoub W, Keeffe EB, et al. Transarterial chemoinfusion for hepatocellular carcinoma as downstaging therapy and a bridge toward liver transplantation. Am J Transplant 2009; 9:1158-1168.
15. Herrero JI, Sangro B, Pardo F, Quiroga J, Inarrairaequi M, Rotellar F, et al. Liver transplantation in patients with hepatocellular carcinoma across Milan criteria. Liver Transpl 2008; 14:272-278.
16. Yao FY, Kinkhabwala M, LaBerge JM, Bass NM, Brown R Jr, Kerlan R, et al. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transplant 2005; 5: 795-804.
17. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42:1208-1236.
18. Emond JC, Heffron TG, Kortz EO, Gonzalez-Vallina R, Contis JC, Black DD, Whitington PF. Improved results of living related liver transplantation with routine application in a pediatric program. Transplantation 1993; 55:835-840.
19. Katz SM, Ozaki CF, Monsour HP, Fontenot D, Beumann L, Thomas M, et al. Pediatric living related and cadaveric liver transplantation: a single center experience. Transplant Proc 1994; 26:145-146.
20. Reding R,Wallemacq P, Moulin D, Manicourt D, Lambotte L, Jamart J, et al. Early hepatocyte, endothelial and bile duct cell injury after pediatric liver transplantation from cadaveric or living related donors. Transplantation 1998; 66:681-685.
21. Inomata Y, Tanaka K, Egawa H, Uemoto S, Ozaki N, Okajima H, et al. The evolution of immunosuppression with FK506 in pediatric living-related liver transplantation. Transplantation 1996; 61:247-252.
22. Gondolesi GE, Roayaie S, Munoz L, Kim-Schluger L, Schiano T, Fishbein TM, et al. Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg 2004; 239:142-149.
23. Li C, Wen TF, Yan LN, Li B, Yang JY, Wang WT, et al. Outcome of hepatocellular carcinoma treated by liver transplantation: comparison of living donor and deceased donor transplantation. Hepatobiliary Pancreat Dis Int 2010; 9:366-369.
24. Lei J, Yan L. Donor morbidity including biliary complications in living-donor liver transplantation: a single center analysis of 283 cases. Transplantation 2012; 94:e51-e52.
25. Li J, Yan LN, Yang J, Chen ZY, Li B, Zeng Y, et al. Indicators of prognosis after liver transplantation in Chinese hepatocellular carcinoma patients. World J Gastroenterol 2009; 15:4170-4176.
26. Jiang L, Yan L, Li B,Wen T, Zhao J, Jiang L, et al. Prophylaxis against hepatitis B recurrence posttransplantation using lamivudine and individualized lowdose hepatitis B immunoglobulin. Am J Transplant 2010; 10:1861-1869.
27. Maddala YK, Stadheim L, Andrews JC, Burgart LJ, Rosen CB, Kremers WK, et al. Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization. Liver Transpl 2004; 10:449-455.
28. Di Sandro S, Slim AO, Giacomoni A, Lauterio A, Mangoni I, Aseni P, et al. Living donor liver transplantation for hepatocellular carcinoma: long-term results compared with deceased donor liver transplantation. Transplant Proc 2009; 41:1283-1285.
29. Strong RW, Lynch SV, Ong TH, Matsuunami H, Koido Y, Balderson GA. Successful liver transplantation from a living donor to her son. N Engl J Med 1990; 322:1505-1507.
30. Malago M, Sotiropoulos GC, Nadalin S, Valentin-Gamazo C, Paul A, Lang H, et al. Living donor liver transplantation for hepatocellular carcinoma: a single-center preliminary report. Liver Transpl 2006; 12:934-940.
31. Lo CM, Fan ST, Liu CL, Chan SC, Ng IO, Wong J. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg 2007; 94:78-86.
32. Fisher RA, Kulik LM, Freise CE, Lok AS, Shearon TH, Brown RS Jr, et al. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant 2007; 7:1601-1608.
33. Maggs JR, Suddle AR, Aluvihare V, Heneghan MA. Systematic review: the role of liver transplantation in the management of hepatocellular carcinoma. Aliment Pharmacol Ther 2012; 35:1113-1134.
34. Lei JY, Yan LN. Comparison between living donor liver transplantation recipients who met the Milan and UCSF criteria after successful downstaging therapies. J Gastrointest Surg 2012; 16:2120-2125.
35. Freise CE, Gillespie BW, Koffron AJ, Lok AS, Pruett TL, Emond JC, et al. Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL retrospective cohort study. Am J Transplant 2008; 8:2569-2579.
36. Kasahara M, Egawa H, Takada Y, Okie F, Sakamoto S, Kiuchi T, et al. Biliary reconstruction in right lobe living donor liver transplantation: Comparison of different techniques in 321 recipients. Ann Surg 2006; 234:559-566.
37. Fan ST, Lo CM, Liu CL, Tso WK, Wong J. Biliary reconstruction and complications of right lobe living donor liver transplantation. Ann Surg 2002; 236:676-683.
38. Takatsuki M, Chiang YC, Lin TS,Wang CC, Concerjero A, Lin CC, et al. Anatomical and technical aspects of hepatic artery reconstruction in living donor liver transplantation. Surgery 2006; 140:824-828.
39. Ko GY, Sung KB, Yoon HK, Lee SG. Early posttransplantation portal vein stenosis following living donor liver transplantation: percutaneous transhepatic primary stent placement. Liver Transpl 2007; 13:530-536.
40. Dumortier J, Adham M, Ber C, Boucaud C, Bouffard Y, Delafosse B, et al. Impact of adult-to-adult living donor liver transplantation on access to transplantation and patients' survival: an 8-year single-center experience. Liver Transpl 2006; 12:1770-1775.
41. Sandhu L, Sandroussi C, Guba M, Selzner M, Ghanekar A, Cattral MS, et al. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence. Liver Transpl 2012; 18:315-322.
42. Sala M, Fuster J, Llovet JM, Navasa M, Sole M, Varela M, et al. High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation. Liver Transpl 2004; 10:1294-1300.
43. Takada Y, Ueda M, Ito T, Sakamoto S, Haga H, Maetani Y, et al. Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma. Liver Transpl 2006; 12:912-919.
44. Roche B, Samuel D. Evolving strategies to prevent HBV recurrence. Liver Transpl 2004; 10 (Suppl 2):S74-S85.
45. Akyildiz M, Karasu Z, Zeytunlu M, Aydin U, Ozacar T, Kilic M. Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis. J Gastroenterol Hepatol 2007; 22:2130-2134.
46. Shiffman ML, Stravitz RT, Contos MJ, Mills AS, Sterling RK, Luketic VA, et al. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation. Liver Transpl 2004; 10: 1248-1255.
47. Russo MW, Galanko J, Beavers K, Fried MW, Shreatha K. Patient and graft survival in hepatitis V recipients after adult living donor liver transplantation in the United States. Liver Transpl 2004; 10:340-346.
48. Bozorgzadeh A, Jain A, Ryan C, Ornt D, Zang M, Mantry P. Impact of hepatitis C virus infection in primary cadaveric liver allograft versus primary living-donor allograft in 100 consecutive liver transplant recipients receiving tacrolimus. Transplantation 2004; 77:1066-1070.
49. Cholongitas E, Papatheodoridis GV, Burroughs AK. Liver grafts from anti-hepatitis B core positive donors: a systematic review. J Hepatol 2010; 52:272-279.